Categories: NewsPharmaceutical

Spexis to host business update conference call on October 9, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ALLSCHWIL, Switzerland, Oct. 05, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, announced today that it will host a business update conference call on October 9, 2023, at 8.30am EDT.

Jeffrey D. Wager, M.D. (CEO & Chairman) will provide strategic business and financial updates. To access the conference call please use the following details:

France: +33 0805102207
Germany: +49 0800-6647650
Italy: +39 800897553
Switzerland +41 0800-002063
United Kingdom +44 08082389064
United States +1 877-317-6789
International Toll Free +1 412-317-6789

Event Title: Spexis AG – Business Update Conference Call

The conference call will also be available via webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=6s6eCE7g

After the call, a replay of the webcast will be available via the above link.

About Spexis

Spexis (SIX: SPEX) is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on macrocycle therapeutics for rare diseases and oncology. For further information please visit: www.spexisbio.com.

For further information please contact:

For Investors: 

Hernan Levett
Chief Financial Officer
Spexis AG.
+41 61 567 16 00
IR@spexisbio.com

Or

Stephen Jasper
Managing Director
Gilmartin Group
stephen@gilmartinir.com

For Media: 

Dr. Stephan Feldhaus
Feldhaus & Partner
+41 79 865 92 56
feldhaus@feldhaus-partner.ch

Staff

Recent Posts

Fresenius Leads New EASYGEN Consortium Aimed at Decentralizing CAR-T Cell Therapy and Improving Hospital Workflows

Physicians, researchers, and partner institutions across Europe aim to deliver innovative, personalized therapies more quickly…

2 hours ago

New Research Highlights Potential of Hydrogen Water to Support Brain Health and Cognitive Function

Peer reviewed studies suggest molecular hydrogen may help protect memory, sharpen focus, and support long-term…

2 hours ago

New Declaration from Carenet Health Urges Healthcare Leaders to Address Unsustainable Costs Stalling Business and Care Outcomes

SAN ANTONIO--(BUSINESS WIRE)--#FutureOfHealthcare--As healthcare organizations contend with rising financial pressures, widespread burnout, and declining patient…

3 hours ago

Europe’s Hospital IT Leaders in Germany, France, and Italy Warn: EHDS Push Outpaces Cyber Defenses

As EHDS interconnects EU systems, hospitals call for patch SLAs, SBOM/VEX transparency, and baseline API…

3 hours ago

Northwell Health Implants Nation’s First Patient with SetPoint System for Treatment of Rheumatoid Arthritis

Treatment follows recent Food and Drug Administration approval of the SetPoint System for treatment of…

5 hours ago

Northwell Health Implants Nation’s First Patient with SetPoint System for Treatment of Rheumatoid Arthritis

Treatment follows recent Food and Drug Administration approval of the SetPoint System for treatment of…

5 hours ago